Results 281 to 290 of about 2,747,113 (394)

Chronic kidney disease of unknown aetiology: a real-world study. [PDF]

BMC Nephrol
Storrar J, Raza S, Baricevic-Jones I, Rengarajan S, Chinnadurai R, Kalra PA, Sinha S.   +6 more
europepmc   +1 more source

Carbon Quantum Dots Assisted Virus Tracking: From Skin to Brain

Advanced Materials, EarlyView.
A novel carbon quantum dots‐dissolvable microneedle, CQDs‐dMN system, enables painless delivery and real‐time tracking of HSV‐1. The HSV‐1 is labeled with fluorescent CQDs and delivered to the skin dermis, minimizing damage compared to traditional methods.
Yaxiu Feng, Xiong Wang, Cien Chen, Di Wang, Changshun Hou, Yiran Wang, Huan Hu, Peiran Chen, LeiYing Qin, Qianya Wan, Xi Yao, Ming‐Liang He   +11 more
wiley   +1 more source

Estimating the global prevalence of secondary hyperparathyroidism in patients with chronic kidney disease

Yichao Wang, Jiaye Liu, Yiqiao Fang, Shengliang Zhou, Xueting Liu, Zhihui Li   +5 more
openalex   +1 more source

Association of dyslipidaemia, chronic kidney disease and hypertension with carotid atherosclerosis in patients with type 2 diabetes mellitus [PDF]

, 2015
Volha Vasilkova, Т. В. Мохорт, Е. П. Науменко, Natalia Filipcova   +3 more
openalex   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

Advanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa, Gracia Mendoza, Silvia Irusta, Manuel Arruebo   +3 more
wiley   +1 more source

Obesity and Chronic Kidney Disease: The Dual Epidemic in Cardiovascular Health. [PDF]

Eur Cardiol
Grant CH, Bell S.
europepmc   +1 more source

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects

Advanced Materials, EarlyView.
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley   +1 more source

Urate-lowering therapy and kidney outcomes in patients with chronic kidney disease and hyperuricemia. [PDF]

Signal Transduct Target Ther
Nie S, Zhou S, Chen R, Li L, Sun Y, Liu J, Jin L, Shao X, Pang M, Su L, Luo F, Xu X, Hou FF.   +12 more
europepmc   +1 more source

Engineering Aging: Approaches to Model and Deconstruct Biological Complexity

Advanced Materials, EarlyView.
The macro‐experiences of aging are the result of an accumulation of micro‐changes that occur over time. Abstract The disparity between the global increase in life expectancy and the steady decline in health outcomes with age has been a major driver for developing new ways to research aging.
Habib Joukhdar, Sunny Shinchen Lee, Thomas R. Cox, Yu Suk Choi, Steven G. Wise, Jennifer L. Young, Giselle C. Yeo, Khoon S. Lim   +7 more
wiley   +1 more source

Ethnic and immigrant disparities in dialysis prevalence and chronic kidney disease trajectories in Toronto. [PDF]

BMJ Open
Sikaneta T, Martin S, Mucsi I, Lofters AK, Taskapan H, Tam P, Mahdavi S.   +6 more
europepmc   +1 more source